Concepedia
Statistics
Publications
11
Citations
308
H-Index
10
Active since
2015
Affiliations
Kyoto University(Current)
Kyoto University Hospital
Hitomi Ajimizu is an author at Kyoto University specializing in medicine, oncology, and pharmacology.
Publications per year
2015–2023
YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation
Takahiro Tsuji, Hiroaki Ozasa, Wataru Aoki et al. · Nature Communications · 2020 · 83 citations · Full text
Medicine, Oncology, Pharmacology +17
MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression
Yuto Yasuda, Hiroaki Ozasa, Young Hak Kim et al. · Cell Death and Disease · 2020 · 51 citations · Full text
Medicine, Oncology, Pharmacology +15
Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
Takahiro Tsuji, Hiroaki Ozasa, Wataru Aoki et al. · Molecular Cancer Research · 2018 · 47 citations · Full text
Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer
Hitomi Ajimizu, Hiroaki Ozasa, Susumu Satô et al. · Scientific Reports · 2021 · 27 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade
Hironori Yoshida, Takashi Nomizo, Hiroaki Ozasa et al. · European Journal of Cancer · 2020 · 21 citations
Medicine, Cancer Biology, Oncology +17
1–5 of 11